Tenet Healthcare Co. (NYSE:THC – Get Free Report) Director J Robert Kerrey sold 5,001 shares of the company’s stock in a transaction on Friday, May 9th. The shares were sold at an average price of $148.50, for a total transaction of $742,648.50. Following the completion of the sale, the director now owns 22,377 shares of the company’s stock, valued at approximately $3,322,984.50. This represents a 18.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
J Robert Kerrey also recently made the following trade(s):
- On Tuesday, March 11th, J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75.
Tenet Healthcare Trading Up 2.3%
Shares of THC stock opened at $158.11 on Wednesday. The firm has a 50 day moving average price of $130.60 and a two-hundred day moving average price of $136.09. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The company has a market capitalization of $14.69 billion, a PE ratio of 4.91, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63. Tenet Healthcare Co. has a 12-month low of $109.82 and a 12-month high of $171.20.
Analyst Upgrades and Downgrades
THC has been the subject of a number of recent analyst reports. Baird R W cut shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Truist Financial increased their target price on Tenet Healthcare from $175.00 to $190.00 and gave the stock a “buy” rating in a report on Monday. Royal Bank of Canada increased their target price on Tenet Healthcare from $183.00 to $189.00 and gave the stock an “outperform” rating in a report on Wednesday, April 30th. UBS Group raised their price objective on Tenet Healthcare from $217.00 to $230.00 and gave the company a “buy” rating in a report on Wednesday, April 30th. Finally, TD Cowen started coverage on Tenet Healthcare in a report on Wednesday, February 26th. They issued a “buy” rating and a $175.00 price objective for the company. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $174.63.
View Our Latest Stock Analysis on Tenet Healthcare
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the business. US Bancorp DE increased its holdings in shares of Tenet Healthcare by 0.8% during the first quarter. US Bancorp DE now owns 8,620 shares of the company’s stock worth $1,159,000 after purchasing an additional 68 shares during the period. Lindbrook Capital LLC increased its holdings in shares of Tenet Healthcare by 5.3% during the first quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock worth $192,000 after purchasing an additional 72 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Tenet Healthcare by 9.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company’s stock worth $119,000 after purchasing an additional 80 shares during the period. Covestor Ltd increased its stake in Tenet Healthcare by 10.4% in the first quarter. Covestor Ltd now owns 873 shares of the company’s stock valued at $117,000 after acquiring an additional 82 shares during the last quarter. Finally, GeoWealth Management LLC increased its stake in Tenet Healthcare by 39.8% in the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock valued at $37,000 after acquiring an additional 84 shares during the last quarter. 95.44% of the stock is owned by institutional investors.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Stories
- Five stocks we like better than Tenet Healthcare
- Energy and Oil Stocks Explained
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Boeing May Be Ready to Take Off After Latest Developments
- Find and Profitably Trade Stocks at 52-Week Lows
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.